
@article{ho_considerations_2011,
	title = {Considerations when prescribing trimethoprim–sulfamethoxazole},
	volume = {183},
	copyright = {© 2011 Canadian Medical Association or its licensors},
	issn = {0820-3946, 1488-2329},
	url = {https://www.cmaj.ca/content/183/16/1851},
	doi = {10.1503/cmaj.111152},
	abstract = {Introduced in 1968, trimethoprim–sulfamethoxazole remains a popular antibiotic because of its low cost, effectiveness and familiarity among clinicians. It is the most frequently prescribed antibiotic for urinary tract infections in Canada.[1][1] Other indications include treatment of infections},
	language = {en},
	number = {16},
	urldate = {2020-07-10},
	journal = {CMAJ},
	author = {Ho, Joanne M.-W. and Juurlink, David N.},
	month = nov,
	year = {2011},
	pmid = {21989472},
	note = {Publisher: CMAJ
Section: Review},
	pages = {1851--1858},
	file = {Full Text PDF:/home/ian/Zotero/storage/4GQ9MK7B/Ho and Juurlink - 2011 - Considerations when prescribing trimethoprim–sulfa.pdf:application/pdf;Snapshot:/home/ian/Zotero/storage/PHRSXBJ6/1851.html:text/html}
}
